Global Gossypol Market

Gossypol Market Size, Share, Growth Analysis, By Type(Gossypol Acetate, Others), By Application(Male Birth Control Pill, Antitumor Drug, Heavy or Irregular Periods, Uterine Fibroids), By Region - Industry Forecast 2024-2031


Report ID: SQMG15E2048 | Region: Global | Published Date: July, 2001
Pages: 157

Gossypol Market Competitive Landscape

The Global Gossypol Market is relatively consolidated, with a very low level of competition. Companies are working on R&D and other initiatives to provide better equipment to their customers and expand their companies globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses to increase market share and profitability.

Gossypol Market Top Player's Company Profiles

  • Sigma-Aldrich
  • Nycomed
  • Shaanxi Panlong Pharmaceutical Group
  • Xi'an North Pharmaceutical
  • Harbin Sanlian Pharmaceutical
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Gossypol Market was valued at USD XX billion in 2019, and it is expected to reach a value of USD XX billion by 2031, at a CAGR of XX% over the forecast period (2024-2031).

The Gossypol Market is relatively consolidated, with a very low level of competition. Companies are working on R&D and other initiatives to provide better equipment to their customers and expand their companies globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses to increase market share and profitability.'Sigma-Aldrich','Nycomed','Shaanxi Panlong Pharmaceutical Group','Xi'an North Pharmaceutical','Harbin Sanlian Pharmaceutical'

Gossypol causes infertility in most animals and, at low doses, spermatogenesis in humans. Gossypol has long been recognized as a naturally occurring polyphenol in a range of medicinal contexts. Oral gossypol appears to impair sperm count and function in 60% to 100% of males. After stopping the medication, 50% to 77% of men's sperm recover within 3-24 months. Sperm levels in roughly 10% of males stay extremely low for more than 4.5 years.

Gossypol has piqued the interest of researchers due to its appealing biological activity, particularly antitumor and antiviral. To minimise toxicity and boost therapeutic impact, gossypol derivatives undergo structural change.

In terms of region, Asia Pacific dominated the Gossypol market in 2021 and is projected to show a similar trend over the forecast period. The use of Gossypol as an oral contraceptive is the key trend observed in the Asia Pacific especially in China. China is the largest producer of cotton and Gossypol is a polyphenol extracted from the cotton plant's seed, roots, and stem. Hence, most of the market is consolidated in China and will be so over the forecast period. However, North America and Europe is projected to show significant growth over the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Gossypol Market

Report ID: SQMG15E2048

$5,300
BUY NOW GET FREE SAMPLE